Guo X - Search Results

1

Correlation between hormone receptor status and depressive symptoms in patients with metastatic breast cancer.

Guo X, Xu J, Ying E, Yu Z, Sun T. Guo X, et al. Oncotarget. 2017 Feb 2;8(31):50774-50781. doi: 10.18632/oncotarget.15037. eCollection 2017 Aug 1. Oncotarget. 2017. PMID: 28881602 Free PMC article.

2

Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer.

Xu J, Sun T, Guo X, Wang Y, Jing M. Xu J, et al. Among authors: guo x. Oncol Lett. 2018 Mar;15(3):2855-2862. doi: 10.3892/ol.2017.7637. Epub 2017 Dec 19. Oncol Lett. 2018. PMID: 29456719 Free PMC article.

3

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67.

Xu J, Guo X, Jing M, Sun T. Xu J, et al. Among authors: guo x. Onco Targets Ther. 2018 Apr 19;11:2269-2275. doi: 10.2147/OTT.S159830. eCollection 2018. Onco Targets Ther. 2018. PMID: 29719409 Free PMC article.

4

Glycogenolysis in Acquired Glioma Resistance to Temozolomide: A Role for the [Ca²⁺]_i-dependent Activation of Na,K-ATPase/ERK_1/2 Signaling.

Xu J, Zhang Y, Guo X, Sun T. Xu J, et al. Among authors: guo x. Front Pharmacol. 2018 Aug 7;9:873. doi: 10.3389/fphar.2018.00873. eCollection 2018. Front Pharmacol. 2018. PMID: 30131700 Free PMC article.

5

Does a ketogenic diet as an adjuvant therapy for drug treatment enhance chemotherapy sensitivity and reduce target lesions in patients with locally recurrent or metastatic Her-2-negative breast cancer? Study protocol for a randomized controlled trial.

Wang Y, Jing MX, Jiang L, Jia YF, Ying E, Cao H, Guo XY, Sun T. Wang Y, et al. Trials. 2020 Jun 5;21(1):487. doi: 10.1186/s13063-020-04429-5. Trials. 2020. PMID: 32503654 Free PMC article.

6

N-((1-(4-Fluorophenyl)-1H-1,2,3-triazol-4-yl)methyl)-2-methylene-3-oxo-olean-12-en-28-amide Induces Apoptosis in Human Breast Cancer Cells by Stimulating Oxidative Stress and Inhibiting the Notch-Akt Signaling Pathway.

Li X, Wang S, Deng N, Guo X, Fu M, Ma Y, Sun T. Li X, et al. Among authors: guo x. Oxid Med Cell Longev. 2022 Apr 27;2022:8123120. doi: 10.1155/2022/8123120. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35528507 Free PMC article.

7

SZC010 suppresses breast cancer development by regulating the PI3K/Akt/NF-κB signaling pathway.

Jiang J, Li X, Xu H, Ma Y, Fu M, Guo X, Sun T, Zheng X. Jiang J, et al. Among authors: guo x. Chin Clin Oncol. 2024 Jun;13(3):34. doi: 10.21037/cco-24-10. Chin Clin Oncol. 2024. PMID: 38984487 Free article.

8

Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells.

Majd MH, Guo X. Majd MH, et al. Among authors: guo x. Anticancer Agents Med Chem. 2023;23(15):1740-1746. doi: 10.2174/1871520623666230511124547. Anticancer Agents Med Chem. 2023. PMID: 37171012

9

Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells.

Majd MH, Guo X. Majd MH, et al. Among authors: guo x. Anticancer Agents Med Chem. 2024;24(5):398. doi: 10.2174/187152062405240209150030. Anticancer Agents Med Chem. 2024. PMID: 38375809

10

Corrigendum to "Structural characterization of modified whey protein isolates using cold plasma treatment and its applications in emulsion oleogels" [Food Chemistry 356 (2021) 129703].

Gong W, Guo XL, Huang HB, Li X, Xu Y, Hu JN. Gong W, et al. Among authors: guo xl. Food Chem. 2025 Jan 24:143024. doi: 10.1016/j.foodchem.2025.143024. Online ahead of print. Food Chem. 2025. PMID: 39863481 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,679 results

Search Page

Filters